This PDF is the current document as it appeared on Public Inspection on 01/03/2013 at 08:45 am.
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting for the aforementioned subcommittee:
Time and Date: 9:00 a.m.-5:00 p.m., February 5, 2013.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron, Kentucky 41018, Telephone: (859) 334-4611, Fax: (859) 334-4619.
Status: Open to the public, but without an oral public comment period. To access by Start Printed Page 733conference call dial the following information: (866) 659-0537, Participant Pass Code 9933701.
Background: The ABRWH was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the compensation program. Key functions of the ABRWH include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for funding, staffing, and operating the ABRWH to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2013.
Purpose: The ABRWH is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is a reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee on Procedures Review was established to aid the ABRWH in carrying out its duty to advise the Secretary, HHS, on dose reconstructions. The Subcommittee on Procedures Review is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor.
Matters to be Discussed: The agenda for the Subcommittee meeting includes discussion of the following ORAU and DCAS procedures: OCAS TIB-0009 (“Estimation of Ingestion Intakes”), DCAS TIB-0013 (“Selected Geometric Exposure Scenario Considerations for External Dose Reconstruction at Uranium Facilities”), DCAS OTIB-0010 (“Best Estimate External Dose Reconstruction for Glovebox Workers”), DCAS IG-001 (“External Dose Reconstruction Implementation Guidelines”), DCAS IG-003 (“Radiation Exposures Covered for Dose Reconstructions under Part B of the Energy Employees Occupational Illness Compensation Program Act”), DCAS IG-005 (“Use of Classified Information”), Program Evaluation Report 014 (“Construction Trades Workers”), Program Evaluation Report 017 (“Evaluation of Incomplete Internal Dose Records from Idaho, Argonne-East and Argonne-West National Laboratories”), Program Evaluation Report 029 (“Hanford”), ORAUT-PROC-0044 (“Special Exposure Cohort”); Discussion of New Summaries of Completed Reviews; and a continuation of the comment-resolution process for other dose reconstruction procedures under review by the Subcommittee.
The agenda is subject to change as priorities dictate.
This meeting is open to the public, but without an oral public comment period. In the event an individual wishes to provide comments, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below in advance of the meeting.
Contact Person for More Information: Theodore Katz, Executive Secretary, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20, Atlanta Georgia 30333, Telephone: (513) 533-6800, Toll Free 1(800)CDC-INFO, Email email@example.com. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2012-31685 Filed 1-3-13; 8:45 am]
BILLING CODE 4163-18-P